NAD precursor could prevent telomere loss
Longevity Technology - 04-Nov-2020Restoring NAD homeostasis could help in ageing diseases with telomere dysfunction
Join the club for FREE to access the whole archive and other member benefits.
Co-Founder & Executive Chairman of ChromaDex
Frank L. Jaksch Jr. is a Co-Founder of the Company and has served as a member of Board since February 2000. Mr. Jaksch served as Chairman of the Board from May 2010 to October 2011 and was its Co-Chairman from February 2000 to May 2010. In June of 2018, Mr. Jaksch transitioned from Chief Executive Officer to Executive Chairman of the Board.
Mr. Jaksch oversees research, strategy and operations for the Company with a focus on scientific and novel products for pharmaceutical and nutraceutical markets.
From 1993 to 1999, Mr. Jaksch served as International Subsidiaries Manager of Phenomenex, a life science supply company where he managed the international subsidiary and international business development divisions.
Mr. Jaksch earned a B.S. in Chemistry and Biology from Valparaiso University.
Visit website: https://www.chromadex.com/bios/frank-l-jaksch/
See also: ChromaDex - An integrated global nutraceutical company devoted to improving the way people age.
Details last updated 05-Nov-2020
10-May-2021 to 14-May-2021
Online event about longevity and wellness organized by Longevity Leaders (LSX) with many speakers included.
Restoring NAD homeostasis could help in ageing diseases with telomere dysfunction